PCR25 Content Validity Assessment of a Newly-Developed Patient-Reported Outcome Measure for Dry Eye Disease (DED), Meibomian Gland Dysfunction (MGD), and Sjogren's Syndrome Dry Eye Disease (SS-DED)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1960
https://www.valueinhealthjournal.com/article/S1098-3015(22)04165-1/fulltext
Title :
PCR25 Content Validity Assessment of a Newly-Developed Patient-Reported Outcome Measure for Dry Eye Disease (DED), Meibomian Gland Dysfunction (MGD), and Sjogren's Syndrome Dry Eye Disease (SS-DED)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04165-1&doi=10.1016/j.jval.2022.09.1960
First page :
Section Title :
Open access? :
No
Section Order :
11509